ACET

Adicet Bio, Inc.

Latest Form 4:Purchase$525KbyRA CAPITAL MANAGEMENT, L.P. (10% Owner) · filed Apr 13, 2026

Adicet Bio, Inc. (ACET) has 8 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Apr 29, 2026.

The most active filer is 10% Owner RA CAPITAL MANAGEMENT, L.P. with 3 filings. Insiders have net bought $929K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Chen Schor
  • Employees:102
  • HQ:Boston, MA, US
  • IPO:2018-01-26

Insider Buying

$6.6M

reported purchases (SEC code P)

Insider Selling

$675K

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Source
Purchase$525KApr 13SEC ↗
Purchase$535KApr 13SEC ↗
Purchase$543KApr 13SEC ↗
Sale$207KApr 9SEC ↗
Sale$468KApr 9SEC ↗
Purchase$5.0MOct 10SEC ↗

Related companies

Adicet Bio, Inc. is in the Healthcare sector.